Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BCLC Stage B Hepatocellular Carcinoma”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Large-scale testing (Phase 3)UnknownNCT03851913
What this trial is testing

The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Beyond Milan Criteria BCLC Stage A/B Hepatocellular Carcinoma Who Underwent Hepatectomy

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 344
Early research (Phase 1)Study completedNCT01666756
What this trial is testing

Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerAdvanced Adult Hepatocellular Carcinoma+2 more
City of Hope Medical Center 18
Testing effectiveness (Phase 2)UnknownNCT04174781
What this trial is testing

Anti-PD-1 Antibody Plus DEB-TACE for BCLC Stage A/B HCC

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University 61
Testing effectiveness (Phase 2)WithdrawnNCT03775707
What this trial is testing

Lenvatinib Plus PD-1 Antibody for Intermediate-stage HCC Beyond Up-to-seven Criteria

Who this might be right for
Hepatocellular Carcinoma
Shi Ming
Not applicableUnknownNCT01470495
What this trial is testing

Combined Treatment of RFA and Sorafenib on Recurrent HCC

Who this might be right for
HCCRadiofrequency AblationSorafenib
Southwest Hospital, China 430
Testing effectiveness (Phase 2)UnknownNCT04204577
What this trial is testing

The Safety and Efficacy of Thermal Ablation Combined With Apatinib and Carilimub for Advanced Liver Cancer

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma
Chinese PLA General Hospital 90
Testing effectiveness (Phase 2)Looking for participantsNCT06741020
What this trial is testing

Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhejiang Cancer Hospital 10
Not applicableLooking for participantsNCT06632093
What this trial is testing

HAIC in Combination with PD-1 Inhibitors and Lenvatinib for Intermediate and Advanced HCC After the Failure of Systemic Therapy Recommended by BCLC

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaHepatic Arterial Infusion Chemotherapy+3 more
First Hospital of China Medical University 84
Early research (Phase 1)Study completedNCT02578602
What this trial is testing

MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage 0 Adult Hepatocellular Carcinoma+6 more
University of Southern California 26
Early research (Phase 1)Active Not RecruitingNCT04605731
What this trial is testing

Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver Cancer

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaLocally Advanced Hepatocellular Carcinoma+7 more
City of Hope Medical Center 25
Large-scale testing (Phase 3)UnknownNCT03642561
What this trial is testing

Evaluation the Treatment Outcome for RFA in Patients With BCLC Stage B HCC in Comparison With TACE

Who this might be right for
Hepatocellular Carcinoma
Fudan University 300
Large-scale testing (Phase 3)UnknownNCT04909866
What this trial is testing

The Efficacy and Safety of TACE, Lenvatinib and Camrelizumab in the Treatment of BCLC Stage B/C Hepatocellular Carcinoma: a Single-arm, Single-center, Open-label Study

Who this might be right for
Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40
Testing effectiveness (Phase 2)Ended earlyNCT05199285
What this trial is testing

A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaLocally Advanced Hepatocellular Carcinoma+8 more
Academic and Community Cancer Research United 15
Not applicableUnknownNCT05889949
What this trial is testing

Microvascular Invasion for Guiding Treatment of Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma

Who this might be right for
RadiomicsHepatocellular Carcinoma (HCC)Transcatheter Arterial Chemoembolization (TACE)+2 more
Sun Yat-sen University 200
Not applicableUnknownNCT04424043
What this trial is testing

Neo-TACE-HAIC for BCLC B Stage HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 280
Testing effectiveness (Phase 2)Ended earlyNCT04442581
What this trial is testing

Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma
University of Washington 2
Not applicableStudy completedNCT07368530
What this trial is testing

Using Machine Learning to Identify Responders to TACE or HAIC for uHCC

Who this might be right for
Unresectable Hepatocellular Carcinoma (HCC)BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma
First Affiliated Hospital, Sun Yat-Sen University 3,000
Testing effectiveness (Phase 2)Ended earlyNCT05537402
What this trial is testing

LOcoregional vs Systemic Therapy in Patients With BCLC Stage B HCC

Who this might be right for
Hepatocellular Carcinoma
University of Texas Southwestern Medical Center 1
Testing effectiveness (Phase 2)Study completedNCT04000737
What this trial is testing

YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)

Who this might be right for
Advanced Hepatocellular Carcinoma
Yiviva Inc. 62
Early research (Phase 1)Not Yet RecruitingNCT06994572
What this trial is testing

Study of CT-01 as Monotherapy and Combination Therapy in Subjects With Intermediate or Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Captor Therapeutics S.A. 141
Load More Results